Erin H. Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Erin H. Yang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ananth Panchamukhi
Baylor College of Medicine , Houston, Texas
1 shared publication Bradley Lembcke
Baylor College of Medicine
1 shared publicationCorina Lopez
Beth Israel Deaconess Medical Center
1 shared publication- Daniel M. Musher
Infectious Diseases Section, Department of Medicine, Baylor College of Medicine , Houston, Texas
1 shared publication - James Howard Acuff
Infectious Diseases Section, Department of Medicine, Baylor College of Medicine , Houston, Texas
1 shared publication - Kenneth L. Muldrew
Department of Pathology and Immunology, Baylor College of Medicine , Houston, Texas
1 shared publication
Latest Publications
- Open Access
- 21 September 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (10)
The Clinical Significance of Streptococcus mitis Bacteremia
Background: Except for their role in bacterial endocarditis, nonpneumococcal Streptococcus mitis group (SMG) bacteria have traditionally been regarded as commensals of the oropharynx. Widespread adoption of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry has increased identification of these organisms and has led to increased concern about their clinical significance. We evaluated SMG bacteremia in a large multicenter cohort to characterize associated clinical syndromes and better define their clinical relevance. Methods: We performed a retrospective review of all adult patients from 2017 to 2025 who had SMG bacteremia at 3 hospitals within the Texas Medical Center. SMG bacteremia was defined as isolation of S mitis, S mitis/oralis, or S mitis group as determined by MALDI-TOF. Clinical syndromes were identified through chart review and assigned using consistent classification approaches informed by physician documentation, imaging, and microbiologic data. Results: Among 253 patients, neutropenia-associated bacteremia was most common (29.6%), followed by pneumonia (9.5%), infective endocarditis (8.7%), skin, soft tissue, or bone infections (7.9%), and other identified sources (12%). No clear source was identified in 9.5% of cases. Only 22.9% were classified as contaminants. High-grade bacteremia was common, with 47% of cases having ≥3 positive blood culture bottles. In contrast, patients in whom SMG was regarded as contaminant nearly always had only a single-bottle positive. Conclusions: Streptococcus mitis group bacteremia was associated with a broad spectrum of clinical syndromes, with most isolates being regarded as representing clinically significant infection.
- 21 September 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (10)
Open AccessThe Clinical Significance of Streptococcus mitis Bacteremia
Background: Except for their role in bacterial endocarditis, nonpneumococcal Streptococcus mitis group (SMG) bacteria have traditionally been regarded as commensals of the oropharynx. Widespread adoption of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry has increased identification of these organisms and has led to increased concern about their clinical significance. We evaluated SMG bacteremia in a large multicenter cohort to characterize associated clinical syndromes and better define their clinical relevance. Methods: We performed a retrospective review of all adult patients from 2017 to 2025 who had SMG bacteremia at 3 hospitals within the Texas Medical Center. SMG bacteremia was defined as isolation of S mitis, S mitis/oralis, or S mitis group as determined by MALDI-TOF. Clinical syndromes were identified through chart review and assigned using consistent classification approaches informed by physician documentation, imaging, and microbiologic data. Results: Among 253 patients, neutropenia-associated bacteremia was most common (29.6%), followed by pneumonia (9.5%), infective endocarditis (8.7%), skin, soft tissue, or bone infections (7.9%), and other identified sources (12%). No clear source was identified in 9.5% of cases. Only 22.9% were classified as contaminants. High-grade bacteremia was common, with 47% of cases having ≥3 positive blood culture bottles. In contrast, patients in whom SMG was regarded as contaminant nearly always had only a single-bottle positive. Conclusions: Streptococcus mitis group bacteremia was associated with a broad spectrum of clinical syndromes, with most isolates being regarded as representing clinically significant infection.
- 26 February 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 47 (5) , 526-529
Comparing the effects of commercial to open initial specimen diversion techniques on clinical outcomes and institutional costs
The clinical outcomes associated with using commercial versus open ISDTs (initial specimen diverting techniques) remain unclear. This multicenter study showed that switching from the commercial to open ISDT did not change blood culture contamination rates, length of stay, or days of therapy with antibiotics, but did reduce laboratory-associated costs.
- 26 February 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 47 (5) , 526-529
Comparing the effects of commercial to open initial specimen diversion techniques on clinical outcomes and institutional costs
The clinical outcomes associated with using commercial versus open ISDTs (initial specimen diverting techniques) remain unclear. This multicenter study showed that switching from the commercial to open ISDT did not change blood culture contamination rates, length of stay, or days of therapy with antibiotics, but did reduce laboratory-associated costs.
- 6 April 2024
- Published by Elsevier in The American Journal of Medicine
- Vol. 137 (8) , 698-701
Practice for Real Life: Diversifying Cases in Educational Conferences
- 6 April 2024
- Published by Elsevier in The American Journal of Medicine
- Vol. 137 (8) , 698-701
Practice for Real Life: Diversifying Cases in Educational Conferences